Regeneron Pharmaceuticals, Inc.

STOREBRAND ASSET MANAGEMENT AS REGN

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/5/2026

Shares

35,939

Value ($000)

27,768

Weight

0.1%

2020 Q1 - 2026 Q1 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/5/2026	27,768	0.1%	35,939	3/31/2026
2025 Q4	5/20/2026	24,806	0.1%	32,137	12/31/2025
2025 Q3	6/3/2026	15,823	0.0%	28,142	9/30/2025
2025 Q2	6/3/2026	14,871	0.0%	28,326	6/30/2025
2025 Q1	6/3/2026	17,377	0.1%	27,398	3/31/2025
2024 Q4	6/17/2026	34,980	0.1%	49,107	12/31/2024
2024 Q3	6/17/2026	60,667	0.2%	57,710	9/30/2024
2024 Q2	6/17/2026	58,014	0.2%	55,197	6/30/2024
2024 Q1	6/17/2026	53,566	0.2%	55,654	3/31/2024
2023 Q4	6/18/2026	50,077	0.2%	57,017	12/31/2023
2023 Q3	6/18/2026	47,877	0.2%	58,176	9/30/2023
2023 Q2	6/18/2026	40,003	0.2%	55,673	6/30/2023
2023 Q1	6/18/2026	50,534	0.3%	61,502	3/31/2023
2022 Q4	6/18/2026	44,035	0.2%	61,034	12/31/2022
2022 Q3	6/18/2026	41,622	0.3%	60,420	9/30/2022
2022 Q2	6/18/2026	36,432	0.2%	61,631	6/30/2022
2022 Q1	6/18/2026	42,637	0.2%	61,048	3/31/2022
2021 Q4	6/18/2026	34,305	0.2%	54,322	12/31/2021
2021 Q3	6/18/2026	32,576	0.2%	53,829	9/30/2021
2021 Q2	6/18/2026	30,058	0.1%	53,816	6/30/2021
2021 Q1	6/18/2026	27,052	0.1%	57,175	3/31/2021
2020 Q4	6/18/2026	26,106	0.2%	54,037	12/31/2020
2020 Q3	6/18/2026	26,169	0.2%	46,749	9/30/2020
2020 Q2	6/18/2026	21,366	0.2%	34,260	6/30/2020
2020 Q1	6/18/2026	16,987	0.2%	34,788	3/31/2020